Salesforce, Inc.
NYSECRM cost to borrow surges to 1.01% — up 201% in one week, highest spike since August. Availability plunges 70% to 2,635%, signaling tightened short supply despite modest 3.4% float short position.
Salesforce reported its Q3 results on September 16, and the stock's 30% one-month rally has drawn a swift and notable response from short sellers — even as the options market and the analyst community both turned more…
CRM approaches its September 16 earnings report with a striking divergence between cautious options positioning and a rapidly deflating short base — two signals that are pulling in opposite directions as the stock…
Snapshot as of 20 Sept 2026
CRM is up 25% on the week and 40% over the past month, yet options traders have not stood down — and that tension carries into the next earnings date on September 16. The analyst community has moved decisively more…
CRM surged 22.6% on its earnings beat. Analysts rushed to raise targets. Yet options traders are the most defensively positioned in 52 weeks — and that tension is the story. Ten firms raised price targets on August 27…
CRM reported Q2 results on August 26 with the bears already largely gone, leaving the post-print debate squarely in the hands of bulls and a cautious analyst middle ground. Short interest has continued its retreat…
CRM enters its August 26 Q2 earnings release having recovered sharply from a rough summer — and the short data confirms that many of its doubters have already covered. Short interest has collapsed by more than a…
CRM enters its August 26 earnings report carrying a striking divergence: short sellers have been covering aggressively while the Street remains split on whether Agentforce is a growth story or a distraction. The most…
Salesforce enters its August 26 earnings window with a fresh Morgan Stanley downgrade reshaping the conversation — even as short sellers quietly retreat and the stock has clawed back some ground. The analyst move is…
Salesforce heads into its August 26 earnings with short interest climbing sharply, analyst sentiment softening, and the stock down to $167.56 — roughly 32% below the Street's average price target. The most striking…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CRM — free to start on ORTEX.
Sign up for free →Open CRM on ORTEX